ArticleJournal of cheminformatics2026
Predicting toxicity and bioactivity of the chemical exposome: a case study for the blood exposome database.
Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
Humans are exposed to thousands of chemicals throughout their life. Many of these chemicals are detected in blood and have been catalogued in the Blood Exposome Database. Comprehensive hazard assessment of a chemical requires time-consuming and costly lab experiments using animal or cell-lines, which cannot be easily scaled up to the chemical exposome, highlighting the urgent need for computational approaches that can prioritize chemicals based on toxicological information. In this study, we trained direct message passing neural networks (D-MPNN) models using the Chemprop framework, chemical structure, and bioactivity data from 9,581 compounds profiled in theTox21 program across 148 quantitative high-throughput screening assays corresponding to distinct biological endpoints. Additionally, we trained a complementary model using chemical structures (n = 264,601) labeled with known UN-GHS classifications for acute oral toxicity. The Tox21 bioactivity and UN-GHS models demonstrated strong predictive performances, with the 47 bioactivity models and the GHS classification model each achieving AUCs greater than 0.80. We applied these high accuracy models to 52,055 chemicals from the Blood Exposome Database to predict bioactivity and the GHS hazard classification, enabling scalable in-silico prioritization of understudied chemical exposures for further toxicological investigations. Data and code are available at https://zenodo.org/records/17560382 and https://github.com/idslme/exposome-toxicity-prediction .Scientific contributions: We have developed an integrated predictive toxicology workflow for exposomics. This unique workflow utilizes Tox21 endpoints, UN-GHS classification and ADME property prediction models, all implemented in the state-of-the-art Chemprop framework, enabling a ranking of exposome compounds for their toxicity potential. By applying it for the Blood Exposome Database, we have prioritized several chemicals that have been detected in blood samples but can be toxic to human health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.